Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Crohn's Disease, Active”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01369355
What this trial is testing

Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)

Who this might be right for
Crohn's DiseaseColitisIBD+1 more
Janssen Research & Development, LLC 1,282
Large-scale testing (Phase 3)Study completedNCT03009396
What this trial is testing

Open Label Efficacy and Safety of Anti-MAP (Mycobacterium Avium Ssp. Paratuberculosis) Therapy in Adult Crohn's Disease

Who this might be right for
Crohn Disease
RedHill Biopharma Limited 54
Early research (Phase 1)Study completedNCT01290042
What this trial is testing

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.

Who this might be right for
Ulcerative ColitisCrohn's Disease
Amgen 43
Testing effectiveness (Phase 2)Looking for participantsNCT06226883
What this trial is testing

Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Who this might be right for
Inflammatory Bowel DiseasesCrohn's Disease
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) 385
Testing effectiveness (Phase 2)Looking for participantsNCT06764615
What this trial is testing

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

Who this might be right for
Crohn's DiseaseUlcerative Colitis
Takeda 192
Large-scale testing (Phase 3)Study completedNCT01369329
What this trial is testing

Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)

Who this might be right for
Crohn's DiseaseIBDColitis+1 more
Janssen Research & Development, LLC 769
Early research (Phase 1)Ended earlyNCT03656627
What this trial is testing

Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease

Who this might be right for
Autoimmune DiseasesNon-small Cell Lung CancerRheumatoid Arthritis+7 more
Alliance Foundation Trials, LLC. 7
Not applicableStudy completedNCT01860651
What this trial is testing

Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel DiseaseUlcerative ColitisCrohn´s Disease
Hvidovre University Hospital 103
Testing effectiveness (Phase 2)Study completedNCT02048618
What this trial is testing

Efficacy and Safety of GLPG0634 in Subjects With Active Crohn's Disease

Who this might be right for
Crohn's Disease
Lakefront Biotherapeutics NV 175
Not applicableStudy completedNCT03241368
What this trial is testing

Clinical Study Comparing PillCam® Crohn's Capsule Endoscopy to Ileocolonoscopy (IC) Plus MRE for Detection of Active CD in the Small Bowel and Colon in Subjects With Known CD and Mucosal Disease.

Who this might be right for
Crohn Disease
Medtronic - MITG 187
Post-approval studies (Phase 4)Ended earlyNCT04966585
What this trial is testing

Pilot Study of Posaconazole in Crohn's Disease

Who this might be right for
Crohn DiseaseCARD9 S12N Risk Allele
Cedars-Sinai Medical Center 10
Early research (Phase 1)Looking for participantsNCT06754891
What this trial is testing

Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease

Who this might be right for
Inflammatory Bowel Diseases
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 135
Large-scale testing (Phase 3)Looking for participantsNCT06100289
What this trial is testing

Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

Who this might be right for
Ulcerative ColitisCrohn's Disease
Takeda 70
Testing effectiveness (Phase 2)Study completedNCT02531113
What this trial is testing

Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Celgene 69
Large-scale testing (Phase 3)Study completedNCT03345836
What this trial is testing

The Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy

Who this might be right for
Crohn's Disease
AbbVie 624
Large-scale testing (Phase 3)Ended earlyNCT00295165
What this trial is testing

Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn Disease
Genzyme, a Sanofi Company 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT05910528
What this trial is testing

Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease

Who this might be right for
Crohns Disease
Hoffmann-La Roche 21
Very early researchStudy completedNCT03962998
What this trial is testing

Oral Administration of MB-102 Versus Dual Sugar Testing for Gut Permeability

Who this might be right for
Crohn Disease
MediBeacon 22
Large-scale testing (Phase 3)Looking for participantsNCT07298421
What this trial is testing

Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease

Who this might be right for
Moderately to Severely Active Crohns Disease
Hoffmann-La Roche 100
Not applicableUnknownNCT02825316
What this trial is testing

Mediterranean Diet as an add-on Therapy for Induction of Remission in Patients With Active Crohn's Disease

Who this might be right for
Crohn's Disease
michal roll 100
Next Page